Pfizer aims to enter the weight loss drug market, with the success hinging on upcoming crucial data
Pfizer is attempting to get a piece of the emerging weight loss medication market as its Covid gains disappear. Future data on Pfizer’s experimental obesity medication, danuglipron, is expected to be significant in determining the company’s ability to compete with Eli Lilly and Novo Nordisk, the market leaders. Some companies, like Novo Nordisk with Wegovy […]